Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy

Neuroscience Letters

Volumn 444, Issue 1, 2008, Pages 112-115

  Daemen, Marc A R C ^a,b   Hoogland, Govert ^a,b   Cijntje, Jean Maurice ^a,b   Spincemaille, Geert H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

GABA transporters; Neuropathy; Rats

Indexed keywords

1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID CARRIER;

ALLODYNIA; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NEUROPATHIC PAIN; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HYPERALGESIA; MALE; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, INBRED LEW; SCIATIC NEUROPATHY; SPINAL CORD; UP-REGULATION;

EID: 50849096715     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.001     Document Type: Article

References (22)

1. Attal N., Jazat F., Kayser V., and Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain 41 (1990) 235-251
2. Backonja M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 59 (2002) S14-S17
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Bhisitkul R.B., Kocsis J.D., Gordon T.R., and Waxman S.G. Trophic influence of the distal nerve segment on GABAA receptor expression in axotomized adult sensory neurons. Exp. Neurol. 109 (1990) 273-278
5. Borden L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29 (1996) 335-356
6. Castro-Lopes J.M., Malcangio M., Pan B.H., and Bowery N.G. Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res. 679 (1995) 289-297
7. Castro-Lopes J.M., Tavares I., and Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res. 620 (1993) 287-291
8. Eaton M.J., Plunkett J.A., Karmally S., Martinez M.A., and Montanez K. Changes in GAD- and GABA-immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J. Chem. Neuroanat. 16 (1998) 57-72
9. Enna S.J., and McCarson K.E. The role of GABA in the mediation and perception of pain. Adv. Pharmacol. 54 (2006) 1-27
10. Hu J.H., Yang N., Ma Y.H., Zhou X.G., Jiang J., Duan S.H., Mei Z.T., Fei J., and Guo L.H. Hyperalgesic effects of gamma-aminobutyric acid transporter I in mice. J. Neurosci. Res. 73 (2003) 565-572
11. Ibuki T., Hama A.T., Wang X.T., Pappas G.D., and Sagen J. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 76 (1997) 845-858
12. Kubová H. NNC-711: an inhibitor of GABA uptake with selective affinity to GAT-1. CNS Drug Rev. 5 (1999) 317-330
13. Leach J.P., and Brodie M.J. Tiagabine. Lancet 351 (1998) 203-207
14. Miletic G., Draganic P., Pankratz M.T., and Miletic V. Muscimol prevents long-lasting potentiation of dorsal horn field potentials in rats with chronic constriction injury exhibiting decreased levels of the GABA transporter GAT-1. Pain 105 (2003) 347-353
15. Minelli A., Brecha N.C., Karschin C., DeBiasi S., and Conti F. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15 (1995) 7734-7746
16. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22 (2002) 6724-6731
17. Ng C.H., and Ong W.Y. Increased expression of gamma-aminobutyric acid transporters GAT-1 and GAT-3 in the spinal trigeminal nucleus after facial carrageenan injections. Pain 92 (2001) 29-40
18. Novak V., Kanard R., Kissel J.T., and Mendell J.R. Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin. Auton. Res. 11 (2001) 357-361
19. Smith C.G., Bowery N.G., and Whitehead K.J. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms. Neuropharmacology 53 (2007) 975-981
20. Soudijn W., and Van Wijngaarden I. The GABA transporter and its inhibitors. Curr. Med. Chem. 7 (2000) 1063-1079
21. Todorov A.A., Kolchev C.B., and Todorov A.B. Tiagabine and gabapentin for the management of chronic pain. Clin. J. Pain 21 (2005) 358-361
22. Xu Y.F., Cai Y.Q., Cai G.Q., Jiang J., Sheng Z.J., Wang Z.G., and Fei J. Hypoalgesia in mice lacking GABA transporter subtype 1. J. Neurosci. Res. 86 (2008) 465-470